Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

2(40%)

Results Posted

33%(1 trials)

Phase Distribution

Ph not_applicable

60%

Ph phase_2

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

2(40.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Detailed Status

Completed3

Active, not recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 22 (40.0%)

N/A3 (60.0%)

Trials by Status

completed360%

active_not_recruiting120%

recruiting120%

Recent Activity

2 active trials

Showing 5 of 5

completedphase_2

RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)

NCT06305806

recruitingnot_applicable

Effectiveness of Coordinated Care to Reduce the Prolonged Disability Risk Among Patients Suffering From Low Back Pain in Primary Care

NCT04826757

active_not_recruitingphase_2

Clinical Trials (5)

Showing 5 of 5 trials

NCT06305806Phase 2

RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)

Completed

NCT04826757Not Applicable

Effectiveness of Coordinated Care to Reduce the Prolonged Disability Risk Among Patients Suffering From Low Back Pain in Primary Care

Recruiting

NCT06305793Phase 2

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)

Active Not Recruiting

NCT01299896Not Applicable

Connect to Quit for Smoking

Completed

NCT00940511Not Applicable

Effects of Coordinated Care for Disabled Medicaid Recipients

Completed

All 5 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 5